Live Breaking News & Updates on Joseph Pantginis Hc Wainwright Co Analyst

Operator
Welcome to the quarter one 2021 Kura Oncology, Inc. Earnings Conference Call. My name is Jenny. I ll be your operator for today s call. [Operator Instructions] I will now turn the call over to Pete De Spain. You may begin.
Pete De Spain
Vice President, Investor Relations and Corporate Communications
Thank you, Jenny. Good afternoon, and welcome to Kura s Oncology s First Quarter 2021 Conference Call. Joining me on the call are Dr. Troy Wilson, our President and Chief Executive Officer; and Dr. Marc Grasso, our Chief Financial Officer and Chief Business Officer. Jim Basta, our Chief Legal Officer; Dr. Stephen Dale, our Chief Medical Officer, Pearson Flowers, our Chief Commercial Officer; and Kathy Ford, our Chief Operating Officer, are also with us and available to answer questions. Before I turn the call over to Dr. Wilson, I would like to remind you that today s call will include forward-looking statements based on current expectations. Such statements ....

United States , Reni John Benjamin , Tiago Felipe Fauth , Marc Grasso , Phil Nadu , Peter Lawson , Stephen Dale , Kathy Ford , Jim Basta , Wei Ji Chang , Philipm Nadeau Cowen , Troy Wilson , Tiago Fauth , Troy Edward Wilson , Joe Pantginis , Reni Benjamin , Jonathan Chang , Peter Richard Lawson Barclays Bank , Cleer Inc , Joseph Pantginis Hc Wainwright Co Analyst , University Of Michigan , Corporate Communications , Kura Oncology Inc , Company Analyst , Translational Research , Cohen Company ,